In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...

Type 1 diabetes is a disease in which the body mistakenly attacks itself as the immune system destroys the pancreas's insulin ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in ...

More than half of psychologists experimented with artificial intelligence tools in their practices in the past year, but ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for ...

The United States is poised to lose its measles-free status next year. If that happens, the country will enter an era in ...